Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Courtney · SciRah

Researcher profile · Semantic Scholar

R. Courtney

Share profile

R. Courtney — researcher profile on SciRah

h-index: 22
Works: 46
Citations: 3,455

Most-cited papers

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer
K. Flaherty, P. LoRusso, A. DeMichele, V. Abramson +6 more
2011Clinical Cancer Research343 citations Open access
Semantic Scholar
Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
R. Courtney, D. Wexler, E. Radwanski, Josephine Lim +1 more
2003British Journal of Clinical Pharmacology332 citations Open access
Semantic Scholar
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.
J. Leonard, A. LaCasce, Mitchell R. Smith, A. Noy +18 more
2012Blood306 citations Open access
Semantic Scholar
Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults
R. Courtney, Sudhakar M. Pai, M. Laughlin, Josephine Lim +1 more
2003Antimicrobial Agents and Chemotherapy302 citations Open access
Semantic Scholar
Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection
A. Ullmann, O. Cornely, A. Burchardt, Ray Y. Hachem +8 more
2006Antimicrobial Agents and Chemotherapy279 citations Open access
Semantic Scholar
Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1)
Gary K. Schwartz, Patricia M. Lorusso, M. Dickson, S. Randolph +4 more
2011British Journal of Cancer267 citations Open access
Semantic Scholar
Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects
P. Krieter, B. Flannery, T. Musick, Mark A. Gohdes +2 more
2004Antimicrobial Agents and Chemotherapy207 citations Open access
Semantic Scholar
Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study.
Deborah J. Wexler, R. Courtney, W. Richards, C. Banfield +2 more
2004European Journal of Pharmaceutical Sciences207 citations
Semantic Scholar
Oral Bioavailability of Posaconazole in Fasted Healthy Subjects
F. Ezzet, D. Wexler, R. Courtney, G. Krishna +2 more
2005Clinical Pharmacokinetics197 citations
Semantic Scholar
Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men
R. Courtney, E. Radwanski, Josephine Lim, M. Laughlin
2004Antimicrobial Agents and Chemotherapy151 citations Open access
Semantic Scholar
Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease
R. Courtney, A. Sansone, W. Smith, T. Marbury +4 more
2005Journal of clinical pharmacology125 citations
Semantic Scholar
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study.
G. Martinelli, V. Oehler, C. Papayannidis, R. Courtney +11 more
2015The Lancet Haematology108 citations
Semantic Scholar
Inhibition of 11β-HSD1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis
J. Tomlinson, M. Sherlock, B. Hughes, S. Hughes +6 more
2007Journal of Clinical Endocrinology and Metabolism100 citations Open access
Semantic Scholar
Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor
R. Courtney, P. Stewart, M. Toh, M. Ndongo +2 more
200882 citations
Semantic Scholar
A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
A. Wagner, W. Messersmith, M. N. Shaik, Sherry Li +6 more
2014Clinical Cancer Research63 citations Open access
Semantic Scholar
Phase 1 Dose-Escalation Study of PF-04449913, An Oral Hedgehog (Hh) Inhibitor, in Patients with Select Hematologic Malignancies
C. Jamieson, J. Cortes, V. Oehler, M. Baccarani +8 more
201151 citations
Semantic Scholar
A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension
R. Schachar, S. Raber, R. Courtney, Min Zhang
2011Current Eye Research48 citations
Semantic Scholar
Phase I study of PD 0332991, cyclin-D kinase (CDK) 4/6 inhibitor in combination with letrozole for first-line treatment of patients with ER-positive, HER2-negative breast cancer.
D. Slamon, S. Hurvitz, S. Applebaum, J. Glaspy +6 more
201031 citations
Semantic Scholar
Modulation of 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11betaHSD1 inhibitor.
R. Courtney, P. Stewart, M. Toh, M. Ndongo +2 more
2008Journal of Clinical Endocrinology and Metabolism31 citations
Semantic Scholar
Phase I trial of SU14813 in patients with advanced solid malignancies.
Walter Fiedler, G. Giaccone, P. Lasch, I. van der Horst +6 more
2011Annals of Oncology26 citations Open access
Semantic Scholar
A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991
P. O'Dwyer, P. LoRusso, A. DeMichele, V. Gupta +6 more
200725 citations
Semantic Scholar
Latanoprost systemic exposure in pediatric and adult patients with glaucoma: a phase 1, open-label study.
S. Raber, R. Courtney, Tomoko Maeda-Chubachi, B. D. Simons +2 more
2011Ophthalmology (Rochester, Minn.)24 citations
Semantic Scholar
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours.
M. D. de Jonge, H. Dumez, J. Kitzen, B. Beuselinck +5 more
2011European Journal of Cancer22 citations Open access
Semantic Scholar
Phase I Study of PD 0332991, a Novel, Oral, Cyclin-D Kinase (CDK) 4/6 Inhibitor in Combination with Letrozole, for First-Line Treatment of Metastatic Post-Menopausal, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer.
R. Finn, S. Hurvitz, M. Allison, S. Applebaum +7 more
200920 citations
Semantic Scholar
Selective CDK 4 / 6 inhibition with tumor responses by PD 0332991 in patients with mantle cell lymphoma *
J. Leonard, A. LaCasce, Mitchell R. Smith, A. Noy +18 more
201217 citations
Semantic Scholar
Treating fungal infections.
R. Courtney, M. Laughlin
1980British medical journal15 citations Open access
Semantic Scholar
A Phase I Study of PD 0332991: Complete CDK4/6 Inhibition and Tumor Response In Sequential Combination with Bortezomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
R. Niesvizky, S. Lentzsch, A. Badros, A. Chanan-Khan +11 more
201014 citations
Semantic Scholar
Assessment of The Pharmacokinetic (PK), Pharmacodynamic (PD) Interaction Potential Between Posaconazole and Glipizide in Healthy Volunteers
R. Courtney, A. Sansone, P. Statkevich, M. Martinho +1 more
20038 citations
Semantic Scholar
Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings
R. Courtney, Candace Gamble, M. L. Arango, Avni N. Shah +3 more
2016Journal of Pediatric Endocrinology & Metabolism (JPEM)7 citations
Semantic Scholar
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
C. Papayannidis, V. Guadagnuolo, I. Iacobucci, S. Durante +18 more
20117 citations
Semantic Scholar
Frequency of safety net errors in the emergency department: Effect of patient handoffs.
Joseph S. Turner, R. Courtney, E. Sarmiento, T. Ellender
2020American Journal of Emergency Medicine6 citations
Semantic Scholar
A Phase I Trial of PD 0332991, a Novel, Orally-Bioavailable CDK4/6-Specific Inhibitor Administered in Combination with Bortezomib and Dexamethasone to Patients with Relapsed and Refractory Multiple Myeloma.
R. Niesvizky, S. Ely, D. Jayabalan, M. Manco +12 more
20096 citations
Semantic Scholar
Gas1 and Kif27 Genes Are Strongly up-Regulated Biomarkers of Hedgehog Inhibition (PF-04449913) on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients
V. Guadagnuolo, C. Papayannidis, I. Iacobucci, S. Durante +18 more
20115 citations
Semantic Scholar
587 Phase 1 Dose-escalation Study of PF-04449913, an Oral Hedgehog Inhibitor in Patients with Select Solid Tumors
A. Wagner, W. Messersmith, N. Shaik, X. Zheng +5 more
20124 citations
Semantic Scholar
A phase I dose-escalation study of the novel gamma secretase inhibitor PF-03084014 in patients (pts) with advanced solid tumors.
W. Messersmith, P. Lorusso, J. Cleary, A. Dasari +5 more
2011Journal of Clinical Oncology4 citations
Semantic Scholar
Efficacy and Safety of PF-03187207, A Novel Nitric Oxide Donating Prostaglandin F2-Alpha Analogue, vs. Latanoprost in Hypertensive Eyes
C. Bosworth, M. Zhang, R. Courtney, S. Raber +2 more
20094 citations
Semantic Scholar
Dose-Escalating, Double-Masked, Vehicle-Controlled Trial of the IOP-Reducing Effect of the EP2 Agonist PF-04217329
R. Schachar, S. Raber, R. Courtney, M. Zhang +1 more
20103 citations
Semantic Scholar
A Model-Based Dose-Response Meta-Analysis of Single Agent Intraocular Pressure (IOP) Therapies Used to Evaluate Efficacy of a Potential New Therapy (PF-03187207) in Glaucoma Patients
D. Nickens, J. Mandema, R. Courtney, S. Raber +1 more
20093 citations
Semantic Scholar
Abstract 906:Gas1andKif27genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients
V. Guadagnuolo, C. Papayannidis, I. Iacobucci, S. Durante +18 more
20122 citations
Semantic Scholar
Phase II/pharmacodynamic trial of PD0332991 in patients with breast, colon, germ cell, and epithelial tumors containing amplification of CCND1.
R. Perini, A. DeMichele, D. Vaughn, M. Gallagher +9 more
2011Journal of Clinical Oncology2 citations
Semantic Scholar
Phase I safety and pharmacokinetic (PK) study of SU014813 (S) in combination with docetaxel (D) in patients (pts) with solid tumors (STs)
P. Schöffski, M. D. de Jonge, H. Dumez, N. Brega +3 more
20082 citations
Semantic Scholar
Pharmacokinetics (PK) of Posaconazole in Subjects With Varying Degrees of Renal Insufficiency
R. Courtney, A. Sansone, P. Statkevich, M. Martinho +2 more
20032 citations
Semantic Scholar
Mineralogical and chemical characterization of newly formed nano-sized minerals in a fulgurite from Outer Banks, NC
Chiara Elmi, R. Courtney
2024Goldschmidt2024 abstracts0 citations Open access
Semantic Scholar
Inhibition of 11 β -HSD1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis
J. Tomlinson, M. Sherlock, B. Hughes, S. Hughes +8 more
20210 citations
Semantic Scholar
Abstract 4619: PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients
C. Papayannidis, V. Guadagnuolo, I. Iacobucci, S. Durante +18 more
20120 citations
Semantic Scholar
Pharmacokinetics (PK) of Latanoprost Acid in Pediatric and Adult Glaucoma Patients Treated With Latanoprost 0.005
S. Raber, R. Courtney, Tomoko Maeda-Chubachi, B. D. Simons +2 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Randolph×8
Invite
S. Randolph — researcher profile on SciRah
W. Levin×8
Invite
W. Levin — researcher profile on SciRah
K. Mclachlan×7
Invite
K. Mclachlan — researcher profile on SciRah
M. Laughlin×6
Invite
M. Laughlin — researcher profile on SciRah

×6

Invite

N. Shaik — researcher profile on SciRah

G. Martinelli×6

Invite

G. Martinelli — researcher profile on SciRah

Invite

V. Oehler — researcher profile on SciRah

C. Papayannidis×6

Invite

C. Papayannidis — researcher profile on SciRah

M. Baccarani×6

Invite

M. Baccarani — researcher profile on SciRah

Invite

J. Cortes — researcher profile on SciRah

Invite

C. Jamieson — researcher profile on SciRah

Invite

S. Raber — researcher profile on SciRah